Robeco Institutional Asset Management B.V. Ligand Pharmaceuticals Inc Transaction History

Robeco Institutional Asset Management B.V.

  • $51.9 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$49.57 - $72.63 $6,543 - $9,587
132 Added 3.71%
3,694 $263,000
Q3 2023

Oct 23, 2023
SELL
$58.86 - $72.67 $125,901 - $155,441
-2,139 Reduced 37.52%
3,562 $213,000
Q2 2023

Jul 24, 2023
BUY
$69.53 - $79.33 $148,724 - $169,686
2,139 Added 60.05%
5,701 $411,000
Q4 2022

Feb 06, 2023
BUY
$61.72 - $96.74 $219,846 - $344,587
3,562 New
3,562 $237,000

Others Institutions Holding LGND

# of Institutions
259
Shares Held
18M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.98B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email